Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RHOQ - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PCDHGB5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYP2C8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ADK - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ROM1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
B3GALT2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C11orf68 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
IGKC - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
PLAC8 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
ZFAND5 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPM1F - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CREB3L1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PSAT1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LAIR1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CAV1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PLEKHB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
DDX21 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
LRMP - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
SRF - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PAK2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on